资讯
1 小时
Zacks Investment Research on MSNGILD Down on Q1 Earnings and Sales Miss, Oncology Sales DeclineGilead Sciences, Inc. GILD reported lower-than-expected first-quarter 2025 results. Adjusted earnings per share (EPS) of $1.81 missed the Zacks Consensus Estimate by a penny. In the year-ago quarter, ...
Using data from the Department of Energy and Tax Foundation, Stacker ranked states from the least to most hospitable for ...
The NFL Draft has become one of the biggest events of the yearly sporting calendar in the US, even though there is no ...
Could the AL East have five teams finish .500 or better? Is the NL East a two-way tussle between the Mets and Phillies or ...
MotorK PLC (AMS: MTRK) ("MotorK", the "Group" or the "Company"), a leading SaaS provider to the automotive retail industry in the EMEA region, today announced its financial results ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果